Venous Clinical Severity Score (VCSS)
Quantifies severity of chronic venous disease using 10 attributes (revised VCSS, American Venous Forum 2010). Designed to measure change over time and after treatment.
Score interpretation
Revised VCSS: higher = more severe chronic venous disease. There are no validated severity cut-offs — use the score to track change over time and after treatment.
→ Interpret with the CEAP class and duplex findings; repeat after treatment to measure the response. Venous ulcer or skin changes: refer to a vascular service (NICE CG168).
Interpretation bands for the VCSS. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Fentanyl Transdermal Patch (Elderly Chronic Pain) · Opioid Analgesic — Transdermal Patch
- Morphine Slow-Release (Elderly Chronic Pain) · Opioid Analgesic — Modified-Release Oral
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.